Never say “never”? I guess I overlooked that memo. In case you missed it, the last two columns were written about what you should never do with control limits. These three nevers, if avoided, will ensure that your control charts are useful, reliable tools.

(Zimmer Holdings Inc.: Warsaw, Indiana) -- Zimmer Holdings Inc.

(Washington, D.C.) — Republican senator Chuck Grassley of Iowa has asked for an independent assessment of how the Food and Drug Administra

(Research and Markets: Dublin, Ireland) – A Frost & Sullivan research service titled “Automation and Control Solutions in the European Pharmaceutical Market” provides an analysis of the various factors driving and restraining the market, revenue forecasts, geographic trends and competit

(Pharmaceutical Technology Magazine: Iselin, New Jersey) – QPEC’s Annual Quality and Process Excellence Conference will be held from July 21-23 at

From the perspective of the U.S.